TrialDrugs in R&D2026

Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study.

Sudershan Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.